Posts Tagged ‘adult stem cells’

Suzanne Somers: How Doctors Used Stem Cell Technology to Rebuild My Breast

Sunday, February 5th, 2012

At 63 years of age, Suzanne Somers is a true inspiration.  In an article from News Max Health (written by Kathleen Walter and Nick Tate), Suzanne shares her latest breakthrough.

Suzanne Somers agonized over the decision to use a  cutting-edge stem cell technology to reconstruct the breast she lost to cancer.  When she began researching the procedure, it wasn’t being offered in the United  States. Women who wanted to have it performed had to travel to Asia, Germany, or  the Dominican Republic.

In an exclusive video interview with Newsmax Health (shown below), Suzanne  details how she was able to work with doctors at Hollywood  Presbyterian Hospital and federal officials to gain approval to become the first  woman in America to undergo the pioneering technique.

It’s the most incredible advancement in breast cancer treatment that I am aware of,” she says.

The procedure itself is enormously complex, but Suzanne  explains the key elements of the technique.

“Here’s my layman’s interpretation,” she says. “They  took fat from my stomach – boo hoo! – they took that fat and in a highly  technical piece of machinery….whipped the stem cells out.”

By separating out the stem cells, doctors could “clean” them and identify the strongest cells, and discard the weakest ones, she says.

“So it was like the fat was just rich with those  [strongest] stem cells,” Suzanne explains. “And then, again in layman’s terms,  they took something that looked to me like a turkey baster and in the bottom of  this breast they kept injecting, injecting, injecting this fat-and-stem-cell  solution until it blew up to be the same size as the other one.”

Today, she says her new breast is very much like the one  she had before her cancer.

“It’s beautiful, it’s soft, it has full feeling. It’s  all me,” she notes. “And there’s no foreign object, and there’s no scar.”

Somers says she felt it was important for her to undergo  the procedure not just for herself, but to help other women with breast cancer in this  country.

“I am the first woman to legally regrow a breast in the  United States,” she says. “It took me three years to get permission … with  Hollywood Presbyterian Hospital, to qualify me for a clinical trial with the  [Food and Drug Administration].”

She wanted to go through the complex experimental  process here – securing approval from a hospital institutional review board  (IRB) and the FDA – so that other women in this country can benefit from her  experience.

“It was important for me to have it done in the United  States because … we’re almost like a Third World country here, relative to stem  cells,” Suzanne says. “Science is supposed to progress. And the fact that  they’ve put up these road blocks with stem cell protocols is pushing back  science. It feels wrong. Most people have to spend their life savings going  offshore to have this done in a country that’s not theirs with doctors they  don’t know.”

She adds: “I wanted it to be an American achievement by  an American doctor  on an American woman so hopefully my clinical trial will open up the possibility  for women in this country to utilize stem cell protocols. And hopefully this  will be the first option in the future. It’s more humane.”

She acknowledges that the procedure is not simple or  easy, and may not be for everyone.

“Liposuction is not for sissies,” she cautions. “When  they removed fat from my stomach — I’m really happy to have given them that fat — but that hurt like crazy.”

Although she extensively researched the procedure before  having it done, she also acknowledges feeling anxious about it, since she was  the first to undergo the procedure.

“I was a human guinea pig because I was the virgin  operation with Dr. Joel Aronowitz,” she says.

But she says the results were worth all the effort,  pain, and anxiety.

“I cannot tell you what a thrill it is to look down and  see myself whole again,” she says.

“I’ve had a hard time keeping my clothes on it looks so  nice!”

She envisions a day when doctors can remove the cancer  from a woman’s breast and immediately take fat “from whatever part of the body  she wants to get rid of it” and regrow her breast using stem cells. She also  believes the procedure might one day be used to replace other body parts — including limbs and heart valves.

“The future is so clearly in nanotechnology and stem  cells, and I actually feel very proud that I might have opened this door a crack  to stem cell protocols,” she says.

“In the future when we’re able to utilize them, you’ll  be able regrow heart valves and, down the road, limbs. Imagine what this might  mean for enlisted people?”

But for now, she says the message is clear: This  stem-cell procedure can work for women with breast cancer, and she feels she’s in the best position to  raise awareness about it.

“Women listen to me,” she says. “I’ve sold 25 million  books around the world, and they look to me as the alternative layperson face. I  wanted to do this not only for me, but I wanted to do this for them. And, in  fact, I saw in the footage when I came out of the ether, the first thing I said — in my drug haze — is this is a great advance for women.”

To see more on Suzanne’s breast reconstruction procedure, go to her website at: suzannesomers.com..

Coming next week to Newsmax Health: How other women can benefit from stem cell  procedures.

Editor’s Note: Suzanne Somers Interviews the Doctors Quietly Curing  Cancer.

© 2012 Newsmax. All rights reserved.

World-Renowned Cell-Therapy Researcher, Doris Taylor, PhD, Joins Texas Heart Institute at St. Luke’s Episcopal Hospital

Friday, January 27th, 2012
World-renowned cell-therapy researcher, Doris Taylor, PhD, joins Texas Heart Institute at St. Luke’s Episcopal Hospital.
HOUSTON–(EON: Enhanced Online News)–Officials at the Texas Heart Institute (THI) at St. Luke’s Episcopal Hospital (St. Luke’s) announced today that Doris Taylor, PhD, FAHA, FACC, one of the world’s leading cell therapy and cardiac regeneration scientists, will join THI beginning March 1, 2012.

“I am confident that I am joining a regenerative medicine program that is unparalleled. And, given the breadth of innovation and science in Houston, I have every confidence that building solutions for heart diseases not only has a long history, but a bright future.”

Dr. Taylor’s research includes: Cell and gene therapy for treatment of cardiovascular disease; tissue engineering of bioartificial organs and vasculature; cell-based prevention of disease; stem cells and cancer; and holistic approaches to using cell therapy for treating chronic disease.

Most recently, Dr. Taylor and her team garnered international recognition for work involving “whole organ decellularization” by showing they were able to remove existing cells from hearts of laboratory animals and even humans leaving a framework to build new organs. They repopulated the framework with other adult stem cells then provided a blood supply, and the heart regenerated with the characteristics and functions of a revitalized beating heart.

The hope is that this research is an early step toward being able to grow a fully functional human heart in the laboratory. Dr. Taylor has demonstrated that the process works for other organs as well – opening a door in the field of organ transplantation.

It is significant in that the need for transplants continues to grow, while the supply of donor organs remains critically low.

“Dr. Taylor is certainly one of the stars in the adult human stem cell field, and we feel extremely fortunate to have her join our team,” said Dr. James T. Willerson, THI’s President and Medical Director. “Her work fits very well with our mission and goals, and she certainly helps to solidify THI as a leader in cell therapy, which is one of the most promising hopes for treating cardiovascular disease.”

“The chance to work with Dr. Willerson and the THI team as colleagues is very exhilarating. From molecules, to cells, to organs and tissues, we want to create solutions for people with disease,” said Dr. Taylor. “I am confident that I am joining a regenerative medicine program that is unparalleled. And, given the breadth of innovation and science in Houston, I have every confidence that building solutions for heart diseases not only has a long history, but a bright future.”

The move to Houston will also bring her closer to her family, notes Dr. Taylor.

Dr. Taylor has been serving as director of the Center for Cardiovascular Repair and Medtronic Bakken Chair in Integrative Biology and Physiology at the University of Minnesota. Prior to that she was on the faculty as Associate Professor in Cardiology at Duke University Medical Center.

A native of Mississippi, Dr. Taylor holds a B.S. in biology from Mississippi University for Women and a Doctorate in pharmacology from the University of Texas Southwestern Medical School in Dallas.

About the Texas Heart® Institute

The Texas Heart Institute (www.texasheart.org), founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education and improved patient care. Together with its clinical partner, St. Luke’s Episcopal Hospital, it has been ranked among the top 10 cardiovascular centers in the United States by U.S. News & World Report’s annual guide to “America’s Best Hospitals” for the past 21 years. The Texas Heart Institute is also affiliated with the University of Texas (UT) System, which promotes collaboration in cardiovascular research and education among UT and THI faculty at the Texas Heart Institute and other UT components.

About St. Luke’s Episcopal Health System

St. Luke’s Episcopal Health System (StLukesTexas.com) includes St. Luke’s Episcopal Hospital in the Texas Medical Center, founded in 1954 by the Episcopal Diocese of Texas; St. Luke’s The Woodlands Hospital; St. Luke’s Sugar Land Hospital; St. Luke’s Lakeside Hospital; St. Luke’s Patients Medical Center; St. Luke’s Hospital at The Vintage; and St. Luke’s Episcopal Health Charities, a charity devoted to assessing and enhancing community health, especially among the underserved. St. Luke’s Episcopal Hospital is home to the Texas Heart®Institute, which was founded in 1962 by Denton A. Cooley, MD, and is consistently ranked among the top 10 cardiology and heart surgery centers in the country by U.S. News & World Report. Affiliated with several nursing schools and three medical schools, St. Luke’s Episcopal Hospital was the first hospital in Texas named a Magnet hospital for nursing excellence, receiving the award three times.

As reported on http://mms.businesswire.com